BioLineRx (BLRX) Leases (2023 - 2025)
Historic Leases for BioLineRx (BLRX) over the last 3 years, with Q3 2025 value amounting to $724000.0.
- BioLineRx's Leases fell 4821.17% to $724000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $724000.0, marking a year-over-year decrease of 4821.17%. This contributed to the annual value of $967000.0 for FY2024, which is 3166.08% down from last year.
- As of Q3 2025, BioLineRx's Leases stood at $724000.0, which was down 4821.17% from $800000.0 recorded in Q2 2025.
- BioLineRx's 5-year Leases high stood at $1.7 million for Q1 2023, and its period low was $724000.0 during Q3 2025.
- In the last 3 years, BioLineRx's Leases had a median value of $1.4 million in 2024 and averaged $1.2 million.
- As far as peak fluctuations go, BioLineRx's Leases plummeted by 437.76% in 2024, and later plummeted by 4821.17% in 2025.
- Over the past 3 years, BioLineRx's Leases (Quarter) stood at $1.4 million in 2023, then plummeted by 31.66% to $967000.0 in 2024, then decreased by 25.13% to $724000.0 in 2025.
- Its Leases was $724000.0 in Q3 2025, compared to $800000.0 in Q2 2025 and $863000.0 in Q1 2025.